10 clinical trials to watch in the second half of 2026
The biotechnology sector’s upswing accelerated in the first half. Positive results from anticipated trials in lung cancer, Alzheimer’s and multiple autoimmune conditions could add to the momentum.
Read the full article on the original site.
Read Full Article